A, P., E, L., CJ, K., RN, T., BA, P., KE, B., . . . JS, M. (2012). An open-label safety and pharmacokinetics study of duloxetine in pediatric patients with major depression. Journal of Child & Adolescent Psychopharmacology, 22(1), 48. https://doi.org/10.1089/cap.2011.0072
Chicago Style (17th ed.) CitationA, Prakash, Lobo E, Kratochvil CJ, Tamura RN, Pangallo BA, Bullok KE, Quinlan T, Emslie GJ, and March JS. "An Open-label Safety and Pharmacokinetics Study of Duloxetine in Pediatric Patients with Major Depression." Journal of Child & Adolescent Psychopharmacology 22, no. 1 (2012): 48. https://doi.org/10.1089/cap.2011.0072.
MLA (9th ed.) CitationA, Prakash, et al. "An Open-label Safety and Pharmacokinetics Study of Duloxetine in Pediatric Patients with Major Depression." Journal of Child & Adolescent Psychopharmacology, vol. 22, no. 1, 2012, p. 48, https://doi.org/10.1089/cap.2011.0072.